Carter E. Hall
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Carter E. Hall has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Wudbhav N. Sankar
The Children’s Hospital of Philadelphia, Philadelphia, PA
2 shared publications - Adam McArthur
The University of Alberta, Edmonton, AB, Canada
1 shared publication - Andrew M. George
Division of Human Genetics Children's Hospital of Philadelphia Philadelphia Pennsylvania USA
1 shared publication - Carlos Yaya-Quezada
Department of Radiology, Section of Musculoskeletal Imaging, The Children’s Hospital of Philadelphia, Philadelphia, USA
1 shared publication Carolyn Gerace
Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
1 shared publicationCharles A Phillips
Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
1 shared publication
Latest Publications
- 17 November 2026
- Published by Wolters Kluwer Health in Journal of Pediatric Orthopaedics
3D Ultrasound Measurements Better Predict Residual Acetabular Dysplasia Following Successful Pavlik Treatment of DDH Compared With 2D Metrics Alone
Background: Pavlik harnesses are largely successful in treating infantile developmental dysplasia of the hip (DDH). However, 5% to 30% of patients “successfully” treated still demonstrate persistent dysplasia on follow-up pelvic radiographs. The purpose of this study was to determine whether 3-dimensional ultrasound (3D US) metrics could more reliably predict residual dysplasia following seemingly “successful” Pavlik harness treatment. Methods: We identified 138 hips in 83 patients with DDH who were treated with a Pavlik and had complete 3D US data sets before harness initiation. At the time the hip was deemed “normal,” weaning was commenced. Forward binary logistic regression of demographics, 2D alpha, beta, and gamma angles, femoral head coverage (FHC), and 4 validated 3D metrics [anterior, mid, and posterior alpha angles, and acetabular contact angle (ACA)], from both initial and weaning scans, was conducted. The ACA is the angle between the resultant vector of the ilium and the acetabular surface, which may be more representative of global dysplasia than the conventional alpha angle. Results: In our cohort, 23 of 138 infants (16.6%) demonstrated radiographic dysplasia at 6 months after “successful” Pavlik treatment. In multivariate regression analysis, factors that significantly increased the risk of dysplasia were age at Pavlik wean less than 81 days ( P =0.002, OR=4.34) and acetabular contact angle (ACA) at wean less than 50 degrees ( P =0.0003, OR =2.94). Adding 3D measurements to a multivariate logistic regression model improved the model’s sensitivity for predicting residual dysplasia at 6 months from 4% in a model with 2D measurements to 19% with addition of 3D variables. Conclusions: Conventional 2D US definitions of a “normal” hip (i.e., alpha angle >60 degrees, %FHC >50%) may not be sufficient given a 16.6% incidence of radiographic dysplasia at 6 months. Three-dimensional US variables, such as ACA, significantly improve the accuracy of models for predicting residual dysplasia and may someday help better define what constitutes a truly normal hip following treatment. Level of Evidence: Level III—retrospective comparative study.
- 17 November 2026
- Published by Wolters Kluwer Health in Journal of Pediatric Orthopaedics
3D Ultrasound Measurements Better Predict Residual Acetabular Dysplasia Following Successful Pavlik Treatment of DDH Compared With 2D Metrics Alone
Background: Pavlik harnesses are largely successful in treating infantile developmental dysplasia of the hip (DDH). However, 5% to 30% of patients “successfully” treated still demonstrate persistent dysplasia on follow-up pelvic radiographs. The purpose of this study was to determine whether 3-dimensional ultrasound (3D US) metrics could more reliably predict residual dysplasia following seemingly “successful” Pavlik harness treatment. Methods: We identified 138 hips in 83 patients with DDH who were treated with a Pavlik and had complete 3D US data sets before harness initiation. At the time the hip was deemed “normal,” weaning was commenced. Forward binary logistic regression of demographics, 2D alpha, beta, and gamma angles, femoral head coverage (FHC), and 4 validated 3D metrics [anterior, mid, and posterior alpha angles, and acetabular contact angle (ACA)], from both initial and weaning scans, was conducted. The ACA is the angle between the resultant vector of the ilium and the acetabular surface, which may be more representative of global dysplasia than the conventional alpha angle. Results: In our cohort, 23 of 138 infants (16.6%) demonstrated radiographic dysplasia at 6 months after “successful” Pavlik treatment. In multivariate regression analysis, factors that significantly increased the risk of dysplasia were age at Pavlik wean less than 81 days ( P =0.002, OR=4.34) and acetabular contact angle (ACA) at wean less than 50 degrees ( P =0.0003, OR =2.94). Adding 3D measurements to a multivariate logistic regression model improved the model’s sensitivity for predicting residual dysplasia at 6 months from 4% in a model with 2D measurements to 19% with addition of 3D variables. Conclusions: Conventional 2D US definitions of a “normal” hip (i.e., alpha angle >60 degrees, %FHC >50%) may not be sufficient given a 16.6% incidence of radiographic dysplasia at 6 months. Three-dimensional US variables, such as ACA, significantly improve the accuracy of models for predicting residual dysplasia and may someday help better define what constitutes a truly normal hip following treatment. Level of Evidence: Level III—retrospective comparative study.
- Open Access
- 2 February 2026
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 108 (14) , 1083-1091
Femoral Head Perfusion Varies Widely Following Surgical Reduction for Infantile Developmental Dysplasia of the Hip
Background: Surgical hip reduction is an accepted treatment option for infantile developmental dysplasia of the hip (DDH) but may be complicated by the development of osteonecrosis, recently re-termed proximal femoral growth disturbance (PFGD) . Since the etiology of PFGD is likely related to compromised vascular supply to the femoral head, the need exists for an intraoperative method of assessing changes in femoral head perfusion prior to irreversible injury. This study sought to utilize contrast-enhanced ultrasound (CEUS) to assess intraoperative changes in perfusion following surgical reduction for infantile DDH, with the ultimate goal of predicting and eventually preventing PFGD. Methods: In this prospective study, CEUS was performed before and immediately after surgical reduction and spica casting in infants undergoing surgery for DDH between 4 and 18 months of age. Delta projections were used to quantitatively analyze changes in perfusion, and a statistical analysis was performed to assess the relationships between patient factors, including casting position, and changes in epiphyseal perfusion. Results: The study population of 32 patients included 34 hips, comprising 30 hips of female patients (88.2%) and 4 hips of male patients (11.8%), with a mean age and standard deviation of 9.3 ± 3.3 months. A lower perfusion index following surgical reduction (p = 0.003) was seen in the majority (79.4%) of hips. In the remaining hips, a higher perfusion index was observed following reduction (p = 0.03). The greatest significant decreases in perfusion index were observed in the central region of the femoral head epiphysis (p = 0.002), followed by the peripheral region of the femoral head epiphysis (p = 0.03). Axial abduction was correlated with a post-reduction decrease in perfusion index (r = 0.35; p = 0.04). There was a moderately positive correlation between body mass index (BMI) and a post-reduction change in perfusion index (r = 0.45; p = 0.01). Conclusions: There was wide variation in post-reduction changes in femoral head perfusion after surgical hip reduction and spica casting for infantile DDH, with a gradient of change across the regions of the femoral head. In addition, BMI and in-cast hip position seemed to influence perfusion changes. With continued analysis of these relationships and longer follow-up from our ongoing prospective investigation, we aim to identify the risk factors for PFGD development. Level of Evidence: Therapeutic Level II . See Instructions for Authors for a complete description of levels of evidence.
- 2 February 2026
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 108 (14) , 1083-1091
Open AccessFemoral Head Perfusion Varies Widely Following Surgical Reduction for Infantile Developmental Dysplasia of the Hip
Background: Surgical hip reduction is an accepted treatment option for infantile developmental dysplasia of the hip (DDH) but may be complicated by the development of osteonecrosis, recently re-termed proximal femoral growth disturbance (PFGD) . Since the etiology of PFGD is likely related to compromised vascular supply to the femoral head, the need exists for an intraoperative method of assessing changes in femoral head perfusion prior to irreversible injury. This study sought to utilize contrast-enhanced ultrasound (CEUS) to assess intraoperative changes in perfusion following surgical reduction for infantile DDH, with the ultimate goal of predicting and eventually preventing PFGD. Methods: In this prospective study, CEUS was performed before and immediately after surgical reduction and spica casting in infants undergoing surgery for DDH between 4 and 18 months of age. Delta projections were used to quantitatively analyze changes in perfusion, and a statistical analysis was performed to assess the relationships between patient factors, including casting position, and changes in epiphyseal perfusion. Results: The study population of 32 patients included 34 hips, comprising 30 hips of female patients (88.2%) and 4 hips of male patients (11.8%), with a mean age and standard deviation of 9.3 ± 3.3 months. A lower perfusion index following surgical reduction (p = 0.003) was seen in the majority (79.4%) of hips. In the remaining hips, a higher perfusion index was observed following reduction (p = 0.03). The greatest significant decreases in perfusion index were observed in the central region of the femoral head epiphysis (p = 0.002), followed by the peripheral region of the femoral head epiphysis (p = 0.03). Axial abduction was correlated with a post-reduction decrease in perfusion index (r = 0.35; p = 0.04). There was a moderately positive correlation between body mass index (BMI) and a post-reduction change in perfusion index (r = 0.45; p = 0.01). Conclusions: There was wide variation in post-reduction changes in femoral head perfusion after surgical hip reduction and spica casting for infantile DDH, with a gradient of change across the regions of the femoral head. In addition, BMI and in-cast hip position seemed to influence perfusion changes. With continued analysis of these relationships and longer follow-up from our ongoing prospective investigation, we aim to identify the risk factors for PFGD development. Level of Evidence: Therapeutic Level II . See Instructions for Authors for a complete description of levels of evidence.
- Open Access
- 15 October 2025
- Published by SAGE Publications in Journal of Children's Orthopaedics
Evolution of discrepancies in limb asymmetry in Beckwith–Wiedemann spectrum
Background: Beckwith–Wiedemann spectrum is a genetic disorder characterized by lateralized overgrowth, often presenting as limb bulk discrepancy. While limb-length discrepancies are documented in Beckwith–Wiedemann spectrum, the natural history of limb bulk discrepancy and hand/foot asymmetry progression remains less studied. This research examines limb bulk discrepancy progression in children with Beckwith–Wiedemann spectrum and identifies factors influencing its severity. Methods: A retrospective, single-institution study analyzed 142 children with molecularly confirmed Beckwith–Wiedemann spectrum (imprinting center 2 loss of methylation, imprinting center 1 gain of methylation, and paternal uniparental isodisomy at chromosome 11). Limb measurements (upper arm, forearm, thigh, calf, palm, finger, and foot) were recorded during clinic visits. Linear mixed-effects models assessed relationships between genotype, age, limb bulk discrepancy progression, body mass index, and sex. Results: The cohort included 90 imprinting center 2 loss of methylation, 41 paternal uniparental isodisomy at chromosome 11, and 11 imprinting center 1 gain of methylation patients. In the imprinting center 2 loss of methylation group, significant limb bulk discrepancy progression occurred in the upper arm (0.47 mm/year), calf (0.53 mm/year), and foot anterior–posterior dimension (0.40 mm/year; all p < 0.01). The paternal uniparental isodisomy at chromosome 11 genotype showed greater asymmetry in most regions compared to others ( p < 0.01), except the middle finger. Asymmetry progression rates were similar across genotypes. Body mass index positively correlated with increased limb bulk discrepancy in the upper arm and calf. Conclusions: Limb asymmetry in Beckwith–Wiedemann spectrum progresses slowly in specific regions, with genotype and body mass index influencing baseline severity. Patients with paternal uniparental isodisomy at chromosome 11 exhibit greater baseline limb bulk discrepancy, but progression rates are consistent across genotypes, highlighting the need for further research into lateralized overgrowth mechanisms and clinical implications. Level of evidence: 3—Retrospective cohort study.
- 15 October 2025
- Published by SAGE Publications in Journal of Children's Orthopaedics
Open AccessEvolution of discrepancies in limb asymmetry in Beckwith–Wiedemann spectrum
Background: Beckwith–Wiedemann spectrum is a genetic disorder characterized by lateralized overgrowth, often presenting as limb bulk discrepancy. While limb-length discrepancies are documented in Beckwith–Wiedemann spectrum, the natural history of limb bulk discrepancy and hand/foot asymmetry progression remains less studied. This research examines limb bulk discrepancy progression in children with Beckwith–Wiedemann spectrum and identifies factors influencing its severity. Methods: A retrospective, single-institution study analyzed 142 children with molecularly confirmed Beckwith–Wiedemann spectrum (imprinting center 2 loss of methylation, imprinting center 1 gain of methylation, and paternal uniparental isodisomy at chromosome 11). Limb measurements (upper arm, forearm, thigh, calf, palm, finger, and foot) were recorded during clinic visits. Linear mixed-effects models assessed relationships between genotype, age, limb bulk discrepancy progression, body mass index, and sex. Results: The cohort included 90 imprinting center 2 loss of methylation, 41 paternal uniparental isodisomy at chromosome 11, and 11 imprinting center 1 gain of methylation patients. In the imprinting center 2 loss of methylation group, significant limb bulk discrepancy progression occurred in the upper arm (0.47 mm/year), calf (0.53 mm/year), and foot anterior–posterior dimension (0.40 mm/year; all p < 0.01). The paternal uniparental isodisomy at chromosome 11 genotype showed greater asymmetry in most regions compared to others ( p < 0.01), except the middle finger. Asymmetry progression rates were similar across genotypes. Body mass index positively correlated with increased limb bulk discrepancy in the upper arm and calf. Conclusions: Limb asymmetry in Beckwith–Wiedemann spectrum progresses slowly in specific regions, with genotype and body mass index influencing baseline severity. Patients with paternal uniparental isodisomy at chromosome 11 exhibit greater baseline limb bulk discrepancy, but progression rates are consistent across genotypes, highlighting the need for further research into lateralized overgrowth mechanisms and clinical implications. Level of evidence: 3—Retrospective cohort study.